Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery

References

• Lammers T, Hennink W, Storm G . Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008;99:392–7
   PubMed Web of Science ®Google Scholar
• Wang M, Thanou M . Targeting nanoparticles to cancer. Pharmacol Res 2010;62:90–9
   PubMed Web of Science ®Google Scholar
• Zhao XB, Muthusamy N, Byrd JC, Lee RJ . Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. J Pharm Sci 2007;96:2424–35
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Mirahmadi N, Babaei MH, Vali AM . Peritoneal retention of liposomes: effects of lipid composition, PEG coating and liposome charge. J Control Release 2010;148:177–86
   PubMed Web of Science ®Google Scholar
• Gabizon A, Price DC, Huberty J, et al. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 1990;50:6371–8
   PubMed Web of Science ®Google Scholar
• Mileykovskaya E, Fishov I, Fu X, et al. Effects of phospholipid composition on MinD-membrane interactions in vitro and in vivo . J Biol Chem 2003;278:22193–8
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P, Cook JM, Florence AT . Nanosystem drug targeting: facing up to complex realities. J Control Release 2010;141:265–76
   PubMed Web of Science ®Google Scholar
• Choi JS, MacKay JA, Szoka FC . Low-pH-sensitive PEG-stabilized plasmid–lipid nanoparticles: preparation and characterization. Bioconjug Chem 2003;14:420–9
   PubMed Web of Science ®Google Scholar
• Mok H, Bae KH, Ahn CH, Park TG . PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir 2009;25:1645–50
   PubMed Web of Science ®Google Scholar
• Sun P, Zhou D, Gan Z . Novel reduction-sensitive micelles for triggered intracellular drug release. J Control Release 2011;155:96–103
   PubMed Web of Science ®Google Scholar
• Xu H, Deng Y, Chen D, et al. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J Control Release 2008;130:238–45
   PubMed Web of Science ®Google Scholar
• Maxwell DM, Lenz DE, Groff WA, et al. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Appl Pharmacol 1987;88:66–76
   PubMed Web of Science ®Google Scholar
• Kuai R, Yuan W, Qin Y, et al. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Mol Pharm 2010;7:1816–26
   PubMed Web of Science ®Google Scholar
• McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV . Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials 2009;30:3986–95
   PubMed Web of Science ®Google Scholar
• Torchilin V. Membrane barriers for bringing drugs inside cells and inside cell organelles. J Membra Sci Technol. 2013;3:e114. doi: https://doi.org/10.4172/2155-9589.1000e114
   Google Scholar
• Futaki S, Hirose H, Nakase I . Arginine-rich peptides: methods of translocation through biological membranes. Curr Pharm Des 2013;19:2863–8
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001;276:5836–40
   PubMed Web of Science ®Google Scholar
• Khalil IA, Kogure K, Futaki S, Harashima H . Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. Int J Pharm 2008;354:39–48
   PubMed Web of Science ®Google Scholar
• Wender PA, Galliher WC, Goun EA, et al. The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev 2008;60:452–72
   PubMed Web of Science ®Google Scholar
• Maeda T, Fujimoto K . A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating. Coll Surf B Biointerfaces 2006;49:15–21
   PubMed Web of Science ®Google Scholar
• Sharma G, Modgil A, Layek B, et al. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection. J Control Release 2013;167:1–10
   PubMed Web of Science ®Google Scholar
• Koren E, Torchilin V . Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 2012;18:385–93
   PubMed Web of Science ®Google Scholar
• Koshkaryev A, Sawant R, Deshpande M, Torchilin V . Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv Drug Deliv Rev 2013;65:24–35
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al. “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjugate Chem 2006;17:943–9
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang L, Liu Y, et al. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes modified with transferrin and TAT. Int J Pharm 2013;454:31–40
   PubMedGoogle Scholar
• Yin Y, Wu X, Yang Z, et al. The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension. Pharm Res 2013;30:2050–62
   PubMed Web of Science ®Google Scholar
• Qin Y, Chen H, Yuan W, et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 2011;419:85–95
   PubMed Web of Science ®Google Scholar
• Ogawara K, Un K, Minato K, et al. Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int J Pharm 2008;359:234–40
   PubMed Web of Science ®Google Scholar
• Nie Y, Duan Y, Zhang Z . Evaluation of blood compatibility of surface modification treated poly (d,l-lactic and glycolic acid) with mPEG block copolymer. J Biomed Eng 2007;24:336–9
   Google Scholar
• Xiong XB, Huang Y, Lu WL, et al. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release 2005;107:262–75
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Ohga N, et al. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. J Control Release 2011;153:141–8
   PubMed Web of Science ®Google Scholar
• Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63
   PubMed Web of Science ®Google Scholar
• Abu Lila AS, Doi Y, Nakamura K, et al. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor. J Control Release 2010;142:167–73
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu T, Su Y, et al. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 2010;31:6612–17
   PubMed Web of Science ®Google Scholar
• Qi XR, Maitani Y, Nagai T . Effect of soybean-derived sterols on the in vitro stability and the blood circulation of liposomes in mice. Int J Pharm 1995;114:33–41
   Google Scholar
• Kuai R, Yuan W, Li W, et al. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration. Mol Pharm 2011;8:2151–61
   PubMed Web of Science ®Google Scholar
• Ogawara K, Un K, Tanaka K, et al. Higaki In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: involvement of cytotoxic effect on vascular endothelial cells. J Control Release 2009;133:4–10
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, et al. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 2011;32:6291–301
   PubMed Web of Science ®Google Scholar
• Mudhakir D, Akita H, Harashima H . Topology of octaarginines (R8) or IRQ ligand on liposomes affects the contribution of macropinocytosis- and caveolae-mediated cellular uptake. React Funct Polym 2011;71:340–3
   Web of Science ®Google Scholar
• Kale AA, Torchilin V . ‘Smart’ drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J Liposome Res 2007;17:197–203
   PubMed Web of Science ®Google Scholar
• Garbuzenko O, Barenholz Y, Priev A . Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids 2005;135:117–29
   PubMed Web of Science ®Google Scholar
• Kenworthy AK, Hristova K, Needham D, McIntosh TJ . Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys J 1995;68:1921–36
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L . Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim Biophys Acta 2009;1788:2259–66
   PubMed Web of Science ®Google Scholar
• Koren E, Apte A, Jani A, Torchilin V . Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Release 2012;160:264–73
   PubMed Web of Science ®Google Scholar
• Hussain S, Pluckthun A, Allen TM, Zangemeister Wittke U . Antitumor activity of an epithelial cell adhesion molecule-targeted nanovesicular drug delivery system. Mol Cancer Ther 2007;6:3019–27
   PubMed Web of Science ®Google Scholar
• Mauk MR, Gamble RC, Baldeschwieler JD . Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice. PNAS 1980;77:4430–4
   PubMed Web of Science ®Google Scholar
• Bae YH . Drug targeting and tumor heterogeneity. J Control Release 2009;133:2–3
   PubMed Web of Science ®Google Scholar
• Greller LD, Tobin FL, Poste G . Tumor heterogeneity and progression: conceptual foundations for modeling. Invasion Metastasis 1996;16:177–208
   PubMedGoogle Scholar